This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Takata, T. Articles by Nikai, H. Search for Related Content PubMed PubMed Citation Articles by Takata, T. Articles by Nikai, H. Pubmed/NCBI databases Genetics Home Reference Social Bookmarking                         What's this?

Immunohistochemical Detection and Distribution of Enamelysin (MMP-20) in Human Odontogenic Tumors

Department of Oral Pathology, ttakata{at}ipc.hiroshima-u.ac.jp

M. Zhao

Department of Oral Pathology

T. Uchida

Department of Oral Anatomy, Faculty of Dentistry, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan

T. Wang

Fuji Chemical Industries, Ltd., Toyama 933-8511, Japan

T. Aoki

Fuji Chemical Industries, Ltd., Toyama 933-8511, Japan

J.D. Bartlett

Department of Biomineralization & Harvard-Forsyth Department of Oral Biology, Forsyth Institute, Boston, MA 02115, USA

H. Nikai

Department of Oral Pathology

Enamelysin is a tooth-specific protease that was initially isolated from porcine enamel organ and subsequently from human odontoblasts. Since this protease is thought to play important roles in tooth development, the evaluation of enamelysin in odontogenic tumors may aid our understanding of the histogenesis and cell differentiation of such lesions. A monoclonal antibody (203-lC7) was generated against synthesized human enamelysin oligopeptide and was used to assess the immunolocalization of enamelysin in healthy developing tooth germs and various types of odontogenic lesions. In tooth germs, enamelysin expression was detected only in the secretory enamel. Thus, 203-1C7 may serve as an enamel-specific marker in the late stage of enamel matrix development and calcification. In odontogenic lesions, strong enamelysin staining was demonstrated in the immature enamel matrix of ameloblastic fibro-odontomas and odontomas. Furthermore, enamelysin was also detected in globular amyloid masses and calcified foci in calcifying epithelial odontogenic tumors, hyaline droplets, small and large mineralized areas in adenomatoid odontogenic tumors, and a portion of ghost cells in calcifying odontogenic cysts. Positive reactivity was also observed in selected tumor cells in some of these tumors. No intracellular staining for enamelysin was detected in ameloblastomas or the ameloblastic portion of ameloblastic fibro-odontomas. Also, enamelysin was not detected in dentin, dysplastic dentinoid hyaline matrices, and cementum that were present within the tumors examined. Thus, taken together, our results suggest that the enamelysin-specific monoclonal antibody (203-1C7) may be utilized as a marker of early enamel development and that enamelysin may be involved in the pathogenesis of specific odontogenic tumors.

Key Words: MMP-20 • enamelysin • odontogenic tumor • immunohistochemistry • antibody.

Journal of Dental Research, Vol. 79, No. 8, 1608-1613 (2000)
DOI: 10.1177/00220345000790081401


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. J. Caterina, Z. Skobe, J. Shi, Y. Ding, J. P. Simmer, H. Birkedal-Hansen, and J. D. Bartlett Enamelysin (Matrix Metalloproteinase 20)-deficient Mice Display an Amelogenesis Imperfecta Phenotype J. Biol. Chem., December 13, 2002; 277(51): 49598 - 49604. [Abstract] [Full Text] [PDF]